Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
The Effect of Acute Peri-Urethral Neurostimulation on Intra-Urethral Pressure In Women With Stress Urinary Incontinence (SUI) - Urodynamic Early Feasibility Study
Corewell Health East
20 participants
Feb 26, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this early feasibility prospective study is to gain initial understanding of the effect of acute peri-urethral neurostimulation on the perineal nerves on intra-urethral pressure.
Eligibility
Inclusion Criteria5
- Female aged 18 years old or older
- Capable of understanding the clinical study procedures and giving informed consent
- Willing and able to undergo the study procedure
- Diagnosis of SUI or stress predominant mixed incontinence, for at least 6 months
- Provided authorization to use and disclose information for research purposes
Exclusion Criteria20
- Predominant urge incontinence per patient report or medical record
- Active symptomatic uncontrolled bladder instability as determined by the investigator
- Regularly or intermittently used a urethral catheter
- Active bladder cancer (currently undergoing or scheduled to undergo treatment for bladder cancer).
- Previous radiation treatment in the pelvic floor
- History or symptoms of cystocele, enterocele or rectocele of grade 3 or 4. Per the medical record or as determined by the investigator
- Current infection (urethritis, cystitis or vaginitis) as determined by investigator.
- Active herpes genitalis
- Unevaluated hematuria
- Currently taking, or has taken within 4 weeks prior to the screening/baseline visit, pharmacological treatment for SUI (including but not limited to, alpha adrenergics, and tricyclic antidepressants)
- Severe or uncontrolled diabetes, (defined as being a diabetic with a hemoglobin A1c of ≥10%) per patient medical record.
- History of drug/alcohol abuse, mental dysfunction, or other factors limiting her ability to cooperate fully
- Pregnancy test with positive result during screening or women who are breastfeeding
- Women who are pregnant and/or have given birth in the previous 12 months
- Have implanted active neurostimulators, pacemakers, or defibrillators; neurostimulators which are passive or that can be briefly turned off for the stimulation procedure are acceptable
- Known systemic neurological dysfunctions
- Severe coagulation disorders
- Medically unstable at time of study and unsafe to undergo urodynamic testing (UDT) as determined by the investigator
- Presence of an artificial urinary sphincter
- Any medical condition (e.g. Multiple Sclerosis, spinal cord injury, mobility) or uncontrolled chronic disease (e.g. renal diseases that requires dialysis) that would interfere with the patient's ability to comply with the protocol and/or may affect the outcome of this study or safety of the subject as determined by the investigator
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A urodynamic test with and without neurostimulation will be conducted. The external neurostimulator device settings will be adjusted to deliver acute nerve stimulation per the individual tolerance level to assess the effect on urethral pressure. A leak point pressure (LLP) during Valsalva maneuver will be assessed with and without acute nerve stimulation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05900570